Drug Type ASO |
Synonyms ART5 (Arnatar Therapeutics), ART 105, ART105 |
Target |
Action inhibitors |
Mechanism PKD1 inhibitors(polycystin 1, transient receptor potential channel interacting inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Polycystic Kidney, Autosomal Dominant | IND Application | China | 14 Apr 2026 |





